Analytical Report for Healthcare Licensing with Focus on Gene Therapy, 2019 Edition - ResearchAndMarkets.com

DUBLIN--()--The "Analytical Report for Healthcare Licensing with focus on Gene Therapy" report has been added to ResearchAndMarkets.com's offering.

Gene therapy has become a trend and most of the companies are banking on breakthrough innovations in the field. Licensing for the development and commercialization of gene and cell therapies are turning into a powerful engine of value creation for pharmaceutical companies, which is analyzed here. 200+ licensing news with a focus on Gene Therapy, during January 1, 2018, to July 31, 2019, are reported and analyzed to provide a snapshot view of the current business trends here.

Analytical data coverage:

  • January 1, 2018, to July 31, 2019, licensing deals and negotiations
  • 200+ worldwide Gene Therapy focused healthcare licensing news of companies across North America (55%), Europe (27%), Asia (17%)
  • Small-mid-large cap companies covered - LargeCap (17%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered - Pharmaceuticals (15%), Biotech (49%), Healthcare Services (27%), Medical Devices (7%)
  • 14 medicine groups studied - Oncology and Genetics (23% each), Neurology (15%)
  • 8+ variables analyzed

User benefits:

  • Immediate access to current global licensing trends for Gene Therapy
  • Succinct summaries of licensing deals and negotiations held worldwide
  • Quick to-the-point analytical references
  • In-depth updates on the wider perspective of Gene Therapy
  • Directions to the emerging business prospects

Key Topics Covered:

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on Gene Therapy licensed during the past 19 months

1.1 Number of licensing deals with a focus on Gene Therapy

1.2 Countries with most licensing deals with a focus on Gene Therapy

1.3 Healthcare sub-sectors with most licensing deals with a focus on Gene Therapy

1.4 Market capitalization groups with most licensing deals with a focus on Gene Therapy

1.5 Medicine groups with most licensing deals with a focus on Gene Therapy

1.6 Leading companies with most licensing deals with a focus on Gene Therapy

1.7 Licensing payment arrangements most followed in licensing deals with a focus on Gene Therapy

Chapter 2: Key licensing deals with a focus on Gene Therapy during the past 19 months - By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Gene Therapy licensed during the past 19 months - By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

For more information about this report visit https://www.researchandmarkets.com/r/db6bxk

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900